Allergology International
Online ISSN : 1440-1592
Print ISSN : 1323-8930
ISSN-L : 1323-8930
Review Series: What We Know, Do Not Know, and Should Know about Severe Asthma
Severe asthma in children: Evaluation and management
Mehtap Haktanir AbulWanda Phipatanakul
著者情報
ジャーナル フリー

2019 年 68 巻 2 号 p. 150-157

詳細
抄録

Severe asthma in children is associated with significant morbidity. Children with severe asthma are at increased risk for adverse outcomes including medication-related side effects, life-threatening exacerbations, and impaired quality of life. It is important to differentiate between severe therapy resistant asthma and difficult-to-treat asthma due to comorbidities. The most common problems that need to be excluded before a diagnosis of severe asthma can be made are poor medication adherence, poor medication technique or incorrect diagnosis of asthma. Difficult to treat asthma is a much more common reason for persistent symptoms and exacerbations and can be managed if comorbidities are clearly addressed. Children with persistent symptoms and exacerbations despite correct inhaler technique and good medical adherence to standard Step 4 asthma therapies according to the guidelines1,2, should be referred to an asthma specialist with expertise in severe asthma.

著者関連情報

この記事は最新の被引用情報を取得できません。

© 2019 by Japanese Society of Allergology
前の記事 次の記事
feedback
Top